Noel Barnard

Noel Barnard serves as the Vice President, Legal and General Counsel at Veloxis Pharmaceuticals, Inc., a role he has held since being promoted in December 2018 after joining the company in March 2016 as Senior Director, Legal Affairs. In this in-house capacity, he is responsible for overseeing all aspects of Veloxis's global legal affairs, which includes managing the company's intellectual property portfolio. His practice is primarily focused on the pharmaceutical and life sciences sector, aligning with Veloxis Pharmaceuticals' business.

Barnard's career demonstrates a consistent focus on the pharmaceutical industry. Before his tenure at Veloxis, he was part of the legal team at Chiesi USA, Inc., where his responsibilities included overseeing the company's intellectual property portfolio and commercial contracting. He also served as Assistant General Counsel at Cornerstone Therapeutics Inc. prior to its acquisition by Chiesi Farmaceutici S.p.A. In patent litigation, his known involvement is primarily on the plaintiff side, representing Veloxis Pharmaceuticals, Inc. in cases such as Veloxis Pharmaceuticals, Inc. v. Glenmark Pharmaceuticals Inc., USA.

Publicly available information does not reliably detail Noel Barnard's specific bar admissions or educational background. Furthermore, there is no verifiable information regarding his direct involvement or regular appearances in Patent Trial and Appeal Board (PTAB) or Inter Partes Review (IPR) proceedings, nor are specific notable litigation outcomes (such as verdicts or Federal Circuit appeals) publicly attributed to him beyond his general oversight of intellectual property.